Literature DB >> 4598850

Microbial kinetics and dependencies of individual and combined antibiotic inhibitors of protein biosynthesis.

E R Garrett, S M Heman-Ackah.   

Abstract

The generation rate constants for the steady-state growth of antibiotic-inhibited Escherichia coli have the same formal dependency on concentration for deoxylincomycin, lincomycin (phase I), erythromycin, clindamycin, and U24729A. They may be kinetically classified as a group A, in which the first three compounds comprise a subgroup A(1) and the latter two a subgroup A(2). Generation rate constants initially decrease linearly with concentration but asymptotically approach zero at higher concentrations. With tetracycline or chloramphenicol, the generation rate decreases linearly with all concentrations, and these compounds may be kinetically classified as group B. Combining an antibiotic from group A with one from group B gives a response equal to that obtained with equivalent amounts of each antibiotic alone, and there are no significant effects from the order of antibiotic addition. However, combinations of an A(1) with an A(2) antibiotic are antagonistic, and there are significant effects from the order of addition. The dependencies of generation rate constants in the presence of these antibiotics can be rationalized by a receptor site model that considers varying degrees of the rate of drug transfer and drug inactivation in the organism.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4598850      PMCID: PMC444598          DOI: 10.1128/AAC.4.5.574

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Substrate and antibiotic binding sites at the peptidyl transferase centre of E. coli ribosomes.

Authors:  M L. Celma; R E. Monro; D Vazquez
Journal:  FEBS Lett       Date:  1970-02-16       Impact factor: 4.124

2.  KINETICS AND MECHANISMS OF ACTION OF ANTIBIOTICS ON MICROORGANISMS. 3. INHIBITORY ACTION OF TETRACYCLINE AND CHLORAMPHENICOL ON ESCHERICHIA COLI ESTABLISHED BY TOTAL AND VIABLE COUNTS.

Authors:  E R GARRETT; G H MILLER
Journal:  J Pharm Sci       Date:  1965-03       Impact factor: 3.534

3.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

4.  Kinetics and mechanisms of drug action on microorganisms. IX. Inhibitory action of lincomycin on Escherichia coli by microbial kinetics.

Authors:  J B Mielck; E R Garrett
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

5.  Kinetics and mechanisms of action of drugs on microorganisms. XI. Effect of erythromycin and its supposed antagonism with lincomycin on the microbial growth of Escherichia coli.

Authors:  E R Garrett; S M Heman-Ackah; G L Perry
Journal:  J Pharm Sci       Date:  1970-10       Impact factor: 3.534

6.  Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin.

Authors:  J M Wilhelm; N L Oleinick; J W Corcoran
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

7.  Quantification and prediction of the biological activities of chloramphenicol analogs by microbial kinetics.

Authors:  E R Garrett; O K Wright; G H Miller; K L Smith
Journal:  J Med Chem       Date:  1966-03       Impact factor: 7.446

8.  Principles of combination chemotherapy.

Authors:  J L Ambrus; C M Ambrus
Journal:  Am J Pharm Sci Support Public Health       Date:  1970 May-Jun

9.  Structure-activity relationships of tetracyclines. I. Inhibition of cell division and protein and nucleic acid syntheses in Escherichia coli W.

Authors:  G H Miller; S A Khalil; A N Martin
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

10.  Peptidyl puromycin synthesis; effect of several antibiotics which act on 50 S ribosomal subunits.

Authors:  K Tanaka; H Teraoka; M Tamaki
Journal:  FEBS Lett       Date:  1971-02-12       Impact factor: 4.124

View more
  4 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli.

Authors:  E R Garrett; C M Won
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

3.  The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.

Authors:  R C Li; J J Schentag; D E Nix
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  Comparison of tetracycline action on Staphylococcus aureus and Escherichia coli by microbial kinetics.

Authors:  S M Heman-Ackah
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.